Clinical Trial Update: Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating the combination of radioembolization with ipilimumab for uveal melanoma with liver metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Uveal Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size | EARLY_Phase 1 | Status: TERMINATED